Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study

Runzhe Chen, Xiaoping Zhang, Chong Gao, Chengxin Luan, Yujie Wang, Baoan Chen Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China Objective: The aim of this retrospective study was to evaluate the efficacy and p...

Full description

Bibliographic Details
Main Authors: Chen R, Zhang X, Gao C, Luan C, Wang Y, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:Cancer Management and Research
Subjects:
multiple myeloma
bortezomib
efficacy
survival
prognostic factors
Online Access:https://www.dovepress.com/treatment-and-prognostic-factors-for-survival-in-newly-diagnosed-multi-peer-reviewed-article-CMAR

Similar Items

Similar Items